The FASEB Journal · 2010 · 81 citations · 40 references
Life SciencesEndocrinologyPharmacologyCarcinogenesisCell SignalingSignal TransductionCytokine BiologyGonadal HormonesHormone ReceptorsHormone SignalingMammary Epithelial Cell BiologySteroid Hormone SignalingDoxycycline-inducible SystemsEstrogen Receptor ExpressionEstrogen Receptor SignalingMammary Branching MorphogenesisMammary Epithelial ArchitectureNf-κb SignalingProgesterone Receptor SignalingProgesterone Receptors
ABSTRACT Despite support for receptor of activated NF‐kB ligand (RANKL) as a mediator of mammary progesterone action, the extent to which this cytokine can functionally contribute to established progesterone‐induced mammary morphogenetic responses in the absence of other presumptive effectors is still unclear. To address this uncertainty, we developed an innovative bigenic system for the doxycycline‐inducible expression of RANKL in the mammary epithelium of the progesterone receptor knockout (PRKO) mouse. In response to acute doxycycline exposure, RANKL is specifically expressed in the estrogen receptor a (ER) positive/progesterone receptor negative (ER + /PR − ) cell type in the PRKO mammary epithelium, a cell type that is equivalent to the ER + /PR + cell type in the wild‐type (WT) mammary epithelium. Notably, the ER + /PR + mammary cell normally expresses RANKL in the WT mammary epithelium during pregnancy. In this PRKO bigenic system, acute doxycycline‐induced expression of RANKL results in ordered mammary ductal side branching and alveologenesis, morphological changes that normally occur in the parous WT mouse. This mammary epithelial expansion is accompanied by significant RANKL‐induced luminal epithelial proliferation, which is driven, in part, by indirect induction of cyclin D1. Collectively, our findings support the conclusion that RANKL represents a critical mediator of mammary PR action and that restricted expression of this effector to the ER + /PR + mammary cell‐type is necessary for a spatially ordered morphogenetic response to progesterone.—Mukherjee, A., Soyal, S. M., Li, J., Ying, Y., He, B., DeMayo, F.J., Lydon, J. P. Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEB J . 24, 4408–4419 (2010). www.fasebj.org
40
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
John P. Lydon, Francesco J. DeMayo, C. Funk et al. · Genes & Development · 1995 · 1.9K citations · Full text
Medicine, Endocrinology, Physiology +17
Regulation of cancer cell migration and bone metastasis by RANKL
D. Holstead Jones, Tomoki Nakashima, Otto Sánchez et al. · Nature · 2006 · 795 citations
Medicine, Cancer Biology, Oncology +14
Control of mammary stem cell function by steroid hormone signalling
Marie-Liesse Asselin-Labat, François Vaillant, Julie M. Sheridan et al. · Nature · 2010 · 698 citations
Progesterone induces adult mammary stem cell expansion
Purna A. Joshi, Hartland W. Jackson, Alexander G. Beristain et al. · Nature · 2010 · 691 citations